InsidersTradesSigma
Track the IBX stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the supervision of ASX. Operating in the Health Care sector, IBX has published 2 public disclosures. Market capitalisation: €6.5m. The latest transaction was disclosed on 1 July 2026 (Purchase). Among the most active insiders: Robert Romeo Proulx. Every trade is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
1 ops.
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations2 total
3,000,000 sharesShareASXASX:2924-03106298-3A696377
50,000 sharesShareASXASX:2924-03088259-3A692988
2 of 2 declarations
关于 IBX
IBX 是一家在 XASX 市场上市的医疗保健和制药领域的公司。